STUDY OF ANTI-MULLERIAN HORMONE LEVELS IN A SAMPLE OF POLYCYSTIC OVARY SYNDROME WOMEN ACROSS AGE GROUPS | ||||
ALEXMED ePosters | ||||
Article 1, Volume 7, Issue 1, January 2025, Page 41-42 | ||||
Document Type: Preliminary preprint short reports of original research | ||||
DOI: 10.21608/alexpo.2025.360128.2095 | ||||
![]() | ||||
Authors | ||||
Salah Abdrabbo1; Ahmed Foad2; Rasha Abdein El-Sayed ![]() | ||||
1Department of Obstetrics and Gynecology, Faculty of Medicine, University of Alexandria. | ||||
2Department of Obstetrics and Gynecology Faculty of Medicine Alexandria University | ||||
3Department of Obstetrics & Gynecology, Faculty of Medicine, Alexandria University. | ||||
Abstract | ||||
INTRODUCTION: Anti-Mullerian hormone (AMH) appears to be the most promising predictor of ovarian reserve in non-PCOS women, regardless of chronological age, of all the hormonal and sonographic approaches tested. Women with PCOS have somewhat similar evidence. PCOS-affected women exhibit higher AMH concentrations than non-PCOS women, suggesting that AMH concentration may be a sign of extended fertility in these women. AIM OF THE WORK: The aim of this study was to predict the age of AMH decline in PCO women. PATIENTS AND METHODS: This was a clinical trial study was carried out on 90 PCO patients in obstetrics and Gynecology department at Elshatby university hospital. RESULTS: The level of AMH show a highly significant difference between the five studied groups, AMH in group I ranged from 4.65-6.5 with mean value 5.60±0.62, in group II ranged from 3.55-5 with mean value 4.15±0.47, in group III ranged from 2.08-3.5 with mean value 2.76±0.46, in group IV ranged from 1.26-3 with mean value 1.94±0.58 and in group V ranged from 0.75-2.43 with mean value 1.26±0.54. There was statistical significant increase in groups I and II than groups III, IV. | ||||
Keywords | ||||
ANTI-MULLERIAN HORMONE; POLYCYSTIC OVARY SYNDROME; Age | ||||
Supplementary Files
|
||||
Statistics Article View: 47 |
||||